In-Q-Tel is a not-for-profit strategic investment organization headquartered in Tysons, Virginia. It invests in frontier technologies that can support the mission needs of US intelligence and national security agencies. Its model is very different from traditional venture capital, as it focuses on identifying commercially developed technologies with potential government and defense applications.

The firm invests across AI, biotech, cyber, quantum, advanced materials, and other dual-use sectors. In areas relevant to neurotechnology, its interest is strongest where products intersect with biosensing, cognitive monitoring, biosecurity, or human performance applications. The key value of In-Q-Tel is its role as a bridge between startups and the US government ecosystem.

Its investments are primarily US-focused, although it scouts technology globally through its international offices. For neurotech, it is most relevant to dual-use platforms with defense, intelligence, or national security applications rather than mainstream clinical neurotech alone. It can be a uniquely strategic partner where neural monitoring or cognitive technologies have government relevance.